Multimedia
View More
Learn about the impact of NASH and the interplay with diabetes, obesity, and cardiovascular disease.
Brent A. Neuschwander-Tetri, MD
Physicians:
maximum of 0.5 AMA PRA Category 1 Credits™
Registered Nurses:
0.5 Nursing contact hours
Pharmacists:
0.5 contact hours (0.05 CEUs)
Released: February 3, 2021
Expired:
February 2, 2022
Learn about the impact of NASH and the interplay with diabetes, obesity, and cardiovascular disease.
Brent A. Neuschwander-Tetri, MD
Released: February 3, 2021
The pathogenesis of NASH is complex, but there’s insight in looking at diabetes, obesity, and insulin resistance through the lens of the liver.
Brent A. Neuschwander-Tetri, MD
Physicians:
maximum of 0.25 AMA PRA Category 1 Credits™
Registered Nurses:
0.25 Nursing contact hours
Pharmacists:
0.25 contact hours (0.025 CEUs)
Released: January 29, 2021
Expired:
January 28, 2022
Learn about who is at risk and who should be evaluated for progression to advanced fibrosis in NASH.
Manal F. Abdelmalek, MD, MPH
Physicians:
maximum of 0.25 AMA PRA Category 1 Credits™
Registered Nurses:
0.25 Nursing contact hours
Pharmacists:
0.25 contact hours (0.025 CEUs)
Released: March 15, 2021
Expired:
March 14, 2022
Learn about who is at risk and should be evaluated for progression to advanced fibrosis in NASH.
Manal F. Abdelmalek, MD, MPH
Released: March 15, 2021
AASLD guidelines do not recommend routine screening for NAFLD or NASH, but they and other guidelines do call out patients with type 2 diabetes as warranting workup.
Manal F. Abdelmalek, MD, MPH
Physicians:
maximum of 0.25 AMA PRA Category 1 Credits™
Registered Nurses:
0.25 Nursing contact hours
Pharmacists:
0.25 contact hours (0.025 CEUs)
Released: March 16, 2021
Expired:
March 15, 2022
Learn how to use noninvasive tests to identify individuals with NAFLD and determine their risk of progression to NASH fibrosis.
Wing-Kin Syn, MBChB, PhD, FACP, FRCP
Physicians:
maximum of 0.5 AMA PRA Category 1 Credits™
Registered Nurses:
0.5 Nursing contact hours
Pharmacists:
0.5 contact hours (0.05 CEUs)
Released: April 27, 2021
Expired:
April 26, 2022
Learn the best tools and approaches to identify NAFLD and to rule in or rule out NASH fibrosis.
Wing-Kin Syn, MBChB, PhD, FACP, FRCP
Released: April 27, 2021
With the many noninvasive tests available for screening those who are at risk for NAFLD/NASH, where should we begin and what is the optimal sequence of testing? Here’s my approach.
Wing-Kin Syn, MBChB, PhD, FACP, FRCP
Physicians:
maximum of 0.25 AMA PRA Category 1 Credits™
Registered Nurses:
0.25 Nursing contact hours
Pharmacists:
0.25 contact hours (0.025 CEUs)
Released: April 20, 2021
Expired:
April 19, 2022
Hear expert insights on the roles of currently available approaches—and the most recent evidence—for managing NASH.
Giada Sebastiani, MD
Physicians:
maximum of 0.25 AMA PRA Category 1 Credits™
Registered Nurses:
0.25 Nursing contact hours
Pharmacists:
0.25 contact hours (0.025 CEUs)
Released: June 2, 2021
Expired:
June 1, 2022
Learn the roles of currently available approaches—and the most recent evidence—for managing NASH.
Giada Sebastiani, MD
Released: June 2, 2021
There are no FDA-approved treatments for NASH. But there are still ways to manage it.
Giada Sebastiani, MD
Physicians:
maximum of 0.25 AMA PRA Category 1 Credits™
Registered Nurses:
0.25 Nursing contact hours
Pharmacists:
0.25 contact hours (0.025 CEUs)
Released: June 2, 2021
Expired:
June 1, 2022
Hear expert insights on emerging approaches for managing NASH, targeting both hepatic and extrahepatic manifestations.
Stephen Harrison, MD, FACP, FAASLD, COL (ret.) USA, MC
Physicians:
maximum of 0.25 AMA PRA Category 1 Credits™
Registered Nurses:
0.25 Nursing contact hours
Pharmacists:
0.25 contact hours (0.025 CEUs)
Released: July 20, 2021
Expired:
July 19, 2022
Hear expert perspectives on histologic and metabolic endpoints in NASH studies and how they may inform potential targets for oral, injectable, and combination NASH treatments.
Stephen Harrison, MD, FACP, FAASLD, COL (ret.) USA, MC
Released: July 20, 2021
My take on how emerging drugs are measuring up.
Stephen Harrison, MD, FACP, FAASLD, COL (ret.) USA, MC
Physicians:
maximum of 0.25 AMA PRA Category 1 Credits™
Registered Nurses:
0.25 Nursing contact hours
Pharmacists:
0.25 contact hours (0.025 CEUs)
Released: September 17, 2021
Expired:
September 16, 2022
Expert recap of highlights from the NASH Core Curriculum, including pathogenesis, risk factors, and current and emerging therapies for patients with NAFLD/NASH.
Stephen Harrison, MD, FACP, FAASLD, COL (ret.) USA, MC
Physicians:
maximum of 0.5 AMA PRA Category 1 Credits™
Registered Nurses:
0.5 Nursing contact hours
Pharmacists:
0.5 contact hours (0.05 CEUs)
Released: September 9, 2021
Expired:
September 8, 2022
Expert recap of highlights from the NASH Core Curriculum, including pathogenesis, risk factors, and current and emerging therapies for patients with NAFLD/NASH.
Stephen Harrison, MD, FACP, FAASLD, COL (ret.) USA, MC
Released: September 9, 2021
Easy-to-read reminders on why and how to look for NAFLD and NASH in your patients.
Download for your patients and their caregivers: patient-friendly overview of the impact of NASH, including its high prevalence and consequences, plus currently recommended approaches to NASH management.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.